instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: No company wants to be the next LM Wind Power. “All it takes is to see something like that happen in a neighboring business or a business similar to yours and everyone gets a lot more fastidious with control measures,” said Dr. Paul Carson, a public health and infectious disease specialist at North Dakota State University, referring to the spread at the Grand Forks plant. Officials with two of the state’s largest plants, window and door maker Marvin and agriculture and construction components producer John Deere Electronic Solutions, say there are new rules of the road. And they’re doing more than the standard protocol of proper hygiene, high-tech protective gear, social distancing and stickers that say, “IF YOU CAN READ THIS YOU ARE TOO CLOSE.” Hallways, entrances, and exits are strictly one-way. Other changes have included temperature checks, unique equipment like “no touch” door openers, liberal leave policies and pay provisions, and an added emphasis on communication between management and workers. ’“The stakes are too high right now,” said Paul Marvin, CEO of Marvin, a century-old Warroad, Minnesota-based company with 6,000 employees in eight states, including 1,300 in the Fargo area. “We want to make people feel comfortable and build trust. It costs you a little money in the short term but it pays dividends in the long run.” The John Deere Electronic Solutions plant in Fargo employs about 750 people. A company spokeswoman said “one of the most impactful steps” they’ve taken is to assure employees that they will be paid if they have symptoms of the virus, don’t feel well or believe they could have been exposed. Marvin employees receive paid leave if they are sick and unpaid leave with health benefits if they just don’t feel comfortable going to work. Paul Marvin said employees don’t have to “prove how sick they are” with notes from their doctors. And their jobs will be waiting for them when they return. North Dakota Gov. Doug Burgum has held up a Canada-based potato processing business as the gold standard for protecting employees from the coronavirus, stating that Cavendish Farms plants in North Dakota and elsewhere have not recorded a single COVID-19 case among thousands of workers. The company employs 250 people at its Jamestown plant. “It has been a family owned-business for decades, taking care of their people,” Burgum said. “They have a culture of safety that has been long established. It’s easy for them to take it up another level.” Cavendish Farms spokeswoman Mary Keith said the numerous safeguards include infrared cameras to monitor the temperatures of people entering buildings and hundreds of signs in multiple languages placed throughout the plants to make employees aware of social distancing and other guidelines. The company purchased 2,700 plexiglass face shields for all of its operations and has added floor-to-ceiling barriers made of plexiglass or wood, she said. “We feel that what we did very well is we reacted early and we reacted fast to the risk and escalated our measures,” Keith said, adding that workers awaiting testing or treatment for COVID-19 receive 10 paid days with health benefits. Meanwhile, the number of infected workers at LM Wind Power stands at about 150 at the Grand Forks plant that employs about 900 people. State and local health officials are undertaking a vigorous contact tracing effort, recruiting dozens of people to help find other COVID-19 cases related to the plant. Some LM employees have complained publicly about what they believed to be a lack of safety precautions, which the company has denied. Officials with the Department of Labor and Human Rights have not received any complaints from LM employees, according to Burgum spokesman Mike Nowatzki. Scott Weislow, Marvin’s director of enterprise risk management, said Marvin had a pandemic blueprint in its library after dealing with the Avian flu and that gave them a head start, he said. “I think we’re going to see an evolution in business; not just us but everybody,” Weislow said. “Working from home will be more acceptable. Some of these social distancing measures are probably going to stick around and you’re going to see other measures like voice activated lights and voice activated door openers.” Carson said when it comes to the coronavirus, even the most stringent measures may not be enough to dodge “the luck of the draw.” It only takes one infected person who’s not showing symptoms to start the spread, he said. Claim: Grand Forks outbreak has other North Dakota plants on alert.
answer:
A widespread outbreak of the coronavirus that has shuttered a wind turbine plant in northeastern North Dakota and initiated a massive contact tracing effort has led many of the state’s largest manufacturers to review and relay their safety measures.


question:
Paragraph: Dr. Chris Baumert, a family physician at RiverStone Health, told the Billings Gazette there’s been a steep increase in the number of cases of syphilis, gonorrhea and chlamydia. The U.S. Centers for Disease Control and Prevention has labeled the threat of antibiotic-resistant gonorrhea one of the nation’s most urgent public health threats. The rate of gonorrhea cases in the United States has increased 75.2 percent since the historic low in 2009. Montana officials are projecting more than 1,000 cases of gonorrhea in the state this year, compared to 867 in 2017. ___ Information from: The Billings Gazette, http://www.billingsgazette.com Claim: STD cases increase in Montana.
answer:
Health officials say cases of sexually transmitted diseases have increased in Montana.


question:
Paragraph: With only six months to go until the United Kingdom is due to leave the European Union, the highly regulated pharmaceuticals industry still does not know exactly how medicines oversight will function. Severin Schwan, chief executive of the world’s biggest maker of cancer drugs, said in an interview that Europe was already slower than the United States to approve new medicines and there are fears the UK might fall further behind, jeopardizing investment. “The UK would get markedly less competitive and less interesting for the industry as a life science hub,” he told Reuters. “For us, this is a very relevant question and if the regulatory system should not keep up with Europe, then this would be a big issue for us.”  Roche employs 2,100 staff in Britain and has been in the country since 1908. Staff work not only in the commercial business but also in a substantial drug development operation. “It goes without saying that we give preference in research and development activities where we bring the medicines to patients first,” Schwan said. “Even though we very much appreciate the science and capabilities in the UK, it is not possible to disconnect that from access to innovative medicines.”  Schwan noted that the UK could, in theory, use Brexit to create an independent drugs regulator that was faster than the European Medicines Agency. However, he also said this would require large government investment in both staff and resources. In addition to uncertainty over the licensing of medicines, Schwan is also frustrated by curbs on access to some treatments within Britain’s National Health Service. His company is in a bitter row over the health service’s refusal to approve Ocrevus, the company’s new drug for treating a highly disabling form of multiple sclerosis. “We now have a situation where patients in need don’t get the medicine. It’s as simple as that,” Schwan said. In preparation for potential supply disruption in the event of Britain leaving the EU without a deal with Brussels, the government has told drugmakers to build an additional six weeks of medicine stockpiles. Schwan said that Roche is increasing its stocks in line with peers and would be able to continue to supply patients in the event of a no-deal Brexit. Claim: Roche boss says Brexit and curbs on drug use pose threat to UK science.
answer:

Uncertainty over drug regulation and a reluctance by Britain’s health service to use certain pricey modern medicines pose a threat to the country’s respected life sciences sector, the head Swiss drugmaker Roche said on Thursday.